Emerging Markets2 years ago
IN8bio, Inc (NASDAQ: INAB): Our Biotech Focus Stock
IN8bio, Inc (NASDAQ: INAB) just released very enticing positive data from their phase 1 investigator-sponsored trial of INB-100 in Leukemia patients. Their NB-100 treatment has been...